Literature DB >> 18790499

T(p-e)/QT ratio as an index of arrhythmogenesis.

Prasad Gupta1, Chinmay Patel, Harsh Patel, Srinivasa Narayanaswamy, Binu Malhotra, Jared T Green, Gan-Xin Yan.   

Abstract

An increasing number of basic and clinical studies have suggested that the interval from the peak to the end of the electrocardiographic T wave (T(p-e)) may correspond to the transmural dispersion of repolarization and that amplification of the T(p-e) interval is associated with malignant ventricular arrhythmias. In this review, we outline the utility of the T(p-e) interval and the T(p-e)/QT ratio as an electrocardiographic index of arrhythmogenesis for both congenital and acquired ion channel disease leading to ventricular arrhythmias. In healthy individuals, the T(p-e)/QT ratio has a mean value of approximately 0.21 in the precordial leads and it remains relatively constant between the heart rates from 60 to 100 beats per minute. Interestingly, the T(p-e)/QT ratio is significantly greater in the patients at risk for arrhythmic event such as those with long QT syndrome, Brugada syndrome, short QT syndrome, and also in patients with organic heart disease such as acute myocardial infarction. Functional reentry is the underlying mechanism for arrhythmogenesis associated with an increased T(p-e)/QT ratio.

Entities:  

Mesh:

Year:  2008        PMID: 18790499     DOI: 10.1016/j.jelectrocard.2008.07.016

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  153 in total

1.  β-blockers protect against dispersion of repolarization during exercise in congenital long-QT syndrome type 1.

Authors:  Lee W Gemma; Gregory M Ward; Mary M Dettmer; Jennifer L Ball; Peter J Leo; Danielle N Doria; Elizabeth S Kaufman
Journal:  J Cardiovasc Electrophysiol       Date:  2011-06-02

Review 2.  The 12-lead electrocardiogram and risk of sudden death: current utility and future prospects.

Authors:  Kumar Narayanan; Sumeet S Chugh
Journal:  Europace       Date:  2015-10       Impact factor: 5.214

3.  Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade.

Authors:  Shaobin Jia; Jiangfan Lian; Donglin Guo; Xiaolin Xue; Chinmay Patel; Lin Yang; Zuyi Yuan; Aiqun Ma; Gan-Xin Yan
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

4.  Normal standards for computer-ECG programs for prognostically and diagnostically important ECG variables derived from a large ethnically diverse female cohort: the Women's Health Initiative (WHI).

Authors:  Pentti M Rautaharju; Zhu-ming Zhang; Richard E Gregg; Wesley K Haisty; Mara Z Vitolins; Anne B Curtis; James Warren; Milan B Horaĉek; Sophia H Zhou; Elsayed Z Soliman
Journal:  J Electrocardiol       Date:  2013-07-01       Impact factor: 1.438

Review 5.  Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development.

Authors:  Vaibhav Salvi; Dilip R Karnad; Gopi Krishna Panicker; Snehal Kothari
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

6.  Association among serum uric acid, cardiovascular risk, and arterial stiffness: a cross-sectional study in She ethnic minority group of Fujian Province in China.

Authors:  Y Lin; X Lai; G Chen; Y Xu; B Huang; Y Wu; Z Chen; L Yao; F Lin; Y Qiao; Z Chen; S Zhu; H Huang; J Wen
Journal:  J Endocrinol Invest       Date:  2011-05-30       Impact factor: 4.256

Review 7.  OSA and Cardiac Arrhythmogenesis: Mechanistic Insights.

Authors:  Anna M May; David R Van Wagoner; Reena Mehra
Journal:  Chest       Date:  2016-09-29       Impact factor: 9.410

Review 8.  Obstructive Sleep Apnea Syndrome as a Trigger of Cardiac Arrhythmias.

Authors:  Julio Martí-Almor; Jesús Jiménez-López; Benjamin Casteigt; Javier Conejos; Ermengol Valles; Núria Farré; Miquel Félez Flor
Journal:  Curr Cardiol Rep       Date:  2021-02-20       Impact factor: 2.931

9.  Effects of the coronary collateral circulation on the Tp-e interval and Tp-e/QT ratio in patients with stable coronary artery disease.

Authors:  Hakan Taşolar; Mehmet Ballı; Mustafa Çetin; Yılmaz Ömür Otlu; Burak Altun; Adil Bayramoğlu
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-06-16       Impact factor: 1.468

10.  Prolonged Tpeak-Tend interval in anti-Ro52 antibody-positive connective tissue diseases.

Authors:  Ayse Nur Tufan; Saim Sag; Mustafa Ferhat Oksuz; Selime Ermurat; Belkis Nihan Coskun; Mustafa Gullulu; Ferah Budak; Ibrahim Baran; Yavuz Pehlivan; Ediz Dalkilic
Journal:  Rheumatol Int       Date:  2016-05-18       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.